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Prep 1.4.Body dysmorphic disorder (BDD) is marked by preoccupation
with misperceived appearance flaws. Previous functional magnetic
resonance imaging (fMRI) studies have found reduced neural activ-
ity and connectivity of visual areas specialized for global/holistic vi-
sual processing in BDD [1e3], suggesting that aberrant dorsal visual
system functioningmight contribute to distorted perception. In this
proof-of-concept study we tested if intermittent theta-burst stimu-
lation (iTBS), a form of excitatory repetitive transcranial magnetic
stimulation (rTMS), would enhance dorsal visual system utilization
as quantified through dynamic effective connectivity (DEC)
modeling [4]. This is a single-session study with the application
of iTBS and an fMRI scan immediately afterwards (within 15min af-
ter the stimulation). We hypothesized that those undergoing active
iTBS would show enhanced connectivity in dorsal visual areas
responsible for global/holistic visual processing compared with
sham.
Fourteen unmedicated adults with BDD, all with face concerns,
were randomly assigned to receive active (n ¼ 7) or sham (n ¼ 7)
offline iTBS (Supplementary Material S1). Stimulation targets
were in the left and right lateral parietal cortical regions corre-
sponding to CP3 and CP4 from the EEG 10-10 system. Stimulation
was applied at 100 % active motor threshold (MT) for the active
group and 10 % active MT for sham (Supplementary Material S2).
The Yale-Brown Obsessive-Compulsive Scale Modified for BDD
(BDD-YBOCS) and the Brown Assessment of Beliefs Scale (BABS)
were administered before the experiment to assess BDD symptoms
and insight, respectively. The Body Image States Scale (BISS) was
administered before and after the experiment to explore iTBS ef-
fects on evaluative/affective experiences of appearance
(SupplementaryMaterial S3). FMRI datawere then immediately ac-
quired after stimulation while participants viewed their face natu-
ralistically (Fig. S1a and Supplementary Material S4eS5).n open access article under the Calyses, fMRI data preprocessing was first done using fMRI-
0 [5] (Supplementary Material S6eS7). Regions-of-interest
(ROIs) were identified through Neurosynth functional meta-
analysis (neurosynth.org). The ROIs included two in primary visual
cortex (V1), six in dorsal visual stream (DVS), and six in ventral vi-
sual stream (VVS) (for exploratory analyses) (Fig. S1b). DEC, a time-
varying measure of directional connectivity among pairs of ROIs,
was computed at each timepoint using time-varying Granger cau-
sality [4]. There were six intra-hemispheric connections, divided
into four categories: DVSLower, DVSHigher, VVSLower, and VVSHigher.
From these connections, the timepoints associated with those trials
of face viewing were extracted for statistical analysis (Fig. S1c and
Supplementary Material S8).
Linear mixed models tested whether DEC was significantly
influenced by treatment group and connectivity categories.
Spearman correlation was used in exploratory follow-up analyses
to determine associations between DEC and clinical measures. As
an additional comparison, given the possibility of sham stimulation
effects, these analyses were also done for data collected separately
from 37 BDD participants and 30 healthy controls during an iden-
tical task of viewing their face naturalistically, but without iTBS be-
forehand. Nonparametric tests were used to analyze the BISS scores
among the four groups (Supplementary Material S9eS10).
From tests of fixed effects, therewas a significant two-way inter-
action between group and connectivity category,
F(3,17290) ¼ 146.48, p < 0.001. From univariate tests, the simple
group effects were significant for DVSHigher, F(1,16.40) ¼ 40.37,
p < 0.001 (active > sham), and for DVSLower, F(1,20.34) ¼ 16.06,
p ¼ 0.001 (active < sham), during face viewing (Fig. 1b). In the
non-iTBS comparison sample, there were no significant differences
between BDD and healthy controls for any of the connectivity cat-
egories (Fig. 1c). Comparing all four groups (active iTBS, sham iTBS,
BDD without iTBS, and controls without iTBS), there was a signifi-
cant two-way interaction between group and connectivity cate-
gory, F(9,40734) ¼ 8.66, p < 0.001, from tests of fixed effects. The
simple group effect was significant for DVSHigher,
F(3,108.8) ¼ 3.19, p ¼ 0.027. BDD participants with active iTBS
exhibited greater DEC for DVSHigher during face viewing compared
to: those with sham iTBS (p ¼ 0.031, Bonferroni-corrected), healthy
controls without iTBS (p ¼ 0.043, Bonferroni-corrected), and BDD
participants without iTBS (p ¼ 0.077, Bonferroni-corrected)
(Fig. S2). Post-hoc, we examined associations between DEC for
DVSHigher and clinical measures. BDD-YBOCS scores significantlyC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Effects of iTBS on DEC patterns and appearance self-evaluations. (a) ROIs and directional connections for DVSHigher and DVSLower. Comparison of DEC patterns for DVSHigher
and DVSLower (b) between BDD participants with active and sham iTBS, and (c) between BDD participants and healthy controls without iTBS. Associations between mean DEC and
clinical scores (d) across BDD participants with iTBS, and (e) across BDD participants without iTBS, during face viewing. (f) Body Image States Scale (BISS) scores were obtained
before and after the experiment from BDD participants who received active iTBS (BDD_ActiveTMS) and sham iTBS (BDD_ShamTMS), and BDD participants (BDD_NoTMS) and
healthy controls (CON_NoTMS) who did not receive iTBS. Higher BISS scores indicate better body image perception.
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(rho ¼ 0.465, p ¼ 0.004, uncorrected) (Fig. 1e). The same pattern
was evident in BDD with iTBS; BDD-YBOCS scores were similarly
correlated negatively with DEC for DVSHigher (rho ¼ 0.480,
p ¼ 0.083, uncorrected) (Fig. 1d). There was also a significant
improvement in BISS in BDD from before to after active iTBS
(p ¼ 0.0497, Bonferroni-corrected). There were no significant
changes in BISS in BDD receiving sham iTBS, or among BDD or
healthy controls who did not receive iTBS (Fig. 1f).1198In this proof-of-concept study, we tested if iTBS alters DVS connec-
tivity in individuals with BDD, as quantified through DECmodeling,
and explored the effects on evaluative/affective experiences of their
physical appearance. Excitatory neuromodulation induced by iTBS
enhanced dynamic connectivity for DVSHigher. This was accompa-
nied by significant improvement in body image (BISS scores) in
active iTBS but not sham iTBS cases. Moreover, the non-iTBS BDD
and control groups showed no significant changes in BISS scores
before and after the experiment.
W.-w. Wong, D. Rangaprakash, M.S. Larson et al. Brain Stimulation 14 (2021) 1197e1200Disturbances of visual information processing in BDD are impor-
tant neurobiological contributors to the psychopathological feature
of perceptual appearance distortions [6]. From our previous neuro-
imaging studies [1e3], abnormally reduced DVS activity was found
in BDD when viewing filtered images that conveyed configural/ho-
listic information. This, in addition to neuropsychological and psy-
chophysical evidence [7e9], contributes to a model of imbalances
in global vs. local processing such that hyper-scrutiny of miniscule
appearance details could be mechanistically related to failing to
“see” the appearance feature as an integrated whole. The current
results provide early evidence that active iTBS over parietal areas
may enhance information transfer within later (“higher”) connec-
tions of the DVSwhich, in turn, may favor global/holistic visual pro-
cessing. Although DEC for DVSLower decreased in active iTBS
compared with sham, the four-group analysis (active iTBS, sham
iTBS, and BDD and healthy controls not receiving iTBS) revealed
that only DVSHigher showed significant group effect. Further,
DVSHigher may have a stronger link to clinical symptoms, as DEC
for DVSHigher but not DVSLower during face viewing was negatively
correlated with BDD symptom severity.
These findings provide evidence of altered dynamic connectiv-
ity in DVS regions responsible for global/configural visual process-
ing when viewing faces naturalistically after excitatory
neuromodulation over parietal areas. The potential clinical rele-
vance is suggested by the significant improvement in evaluative/af-
fective body experiences specifically observed in those with BDD
receiving active iTBS. These results demonstrate that excitatory
neuromodulation may engage DVS connectivity, a potentially
important target that is mechanistically involved in holistic percep-
tion. Given the potential of iTBS to enhance neuroplasticity [10],
these results (with the caveats of a small sample size of those
receiving iTBS and some methodological considerations in
SupplementaryMaterial S11) provide early promise that such inter-
ventions could help remediate perceptual distortions for appear-
ance in those with BDD, and maybe in other disorders with
perceptual disturbances. Future studies measuring global/local vi-
sual processing will be useful to determine if associations between
changes in DVS connectivity and subjective experience are linked
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